Policies, Guidelines and Statements Center

Policy Type
Alaris™ Infusion Central – Recoverable Password Vulnerability
This notification provides product security information and recommendations related to a security vulnerability found within specified versions of Alaris™ Infusion Central, which is not sold in the U.S.
Third-Party Vulnerability LibSSH Authentication Bypass
BD is aware of and currently monitoring a vulnerability in LibSSH library that can result in authentication bypass.
BD BodyGuard™ Pumps – RS-232 Interface Vulnerability
As part of our ongoing efforts to provide product security by design, in use and through partnership, we maintain a program to test third party patches that are important for maintaining the cyber security of BD products.
Third Party Vulnerability Fortinet FortiOS
As part of our ongoing efforts to provide product security by design, in use and through partnership, we maintain a program to test third party patches that are important for maintaining the cyber security of BD products.
Third-Party Software Component End of Support: Microsoft XML Core Services 4.0
As part of our ongoing efforts to provide product security by design, in use and through partnership, we maintain a program to test third party patches that are important for maintaining the cyber security of BD products.
Potential Physical Access to Wireless Credentials Alaris PC Unit PCU model 8015
This notification provides product security information and recommendations related to a security vulnerability found within specified versions of Alaris@{Trade} PC unit model 8015.
Interpeak IPNET TCP IP stack vulnerability
This product security bulletin describes the Interpeak IPNET TCP IP stack vulnerability
BD Alaris™ 8015 PC Unit and BD Alaris™ Systems Manager Network Session Vulnerability
BD Alaris™ 8015 PC Unit and BD Alaris™ Systems Manager Network Session Vulnerability
Third-Party Vulnerability WRECK
BD has assessed nine (9) new Domain Name System (DNS) vulnerabilities affecting four popular TCP/IP network stacks, which could potentially impact medical devices.
BD Synapsys–Insufficient Session Expiration
As part of our ongoing efforts to provide product security by design, in use and through partnership, we maintain a program to test third party patches that are important for maintaining the cyber security of BD products.
Policy Type
- This notification provides product security information and recommendations related to a security vulnerability found within specified versions of Alaris™ Infusion Central, which is not sold in the U.S.
- BD is aware of and currently monitoring a vulnerability in LibSSH library that can result in authentication bypass.
- As part of our ongoing efforts to provide product security by design, in use and through partnership, we maintain a program to test third party patches that are important for maintaining the cyber security of BD products.
- As part of our ongoing efforts to provide product security by design, in use and through partnership, we maintain a program to test third party patches that are important for maintaining the cyber security of BD products.
- As part of our ongoing efforts to provide product security by design, in use and through partnership, we maintain a program to test third party patches that are important for maintaining the cyber security of BD products.
- This notification provides product security information and recommendations related to a security vulnerability found within specified versions of Alaris@{Trade} PC unit model 8015.
- This product security bulletin describes the Interpeak IPNET TCP IP stack vulnerability
- BD Alaris™ 8015 PC Unit and BD Alaris™ Systems Manager Network Session Vulnerability
- BD has assessed nine (9) new Domain Name System (DNS) vulnerabilities affecting four popular TCP/IP network stacks, which could potentially impact medical devices.
- As part of our ongoing efforts to provide product security by design, in use and through partnership, we maintain a program to test third party patches that are important for maintaining the cyber security of BD products.